Drugmakers and pharmaceutical industry groups urged the US Food and Drug Administration (FDA) to align its classification categories for visible particles with the US Pharmacopoeia’s (USP) Chapter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results